icon-    folder.gif   Conference Reports for NATAP  
  International AIDS Conference
Durban, South Africa
July 18-22 2016
Back grey_arrow_rt.gif
Central nervous system impact of vorinostat, hydroxychloroquine and maraviroc combination therapy followed by treatment interruption in individuals treated during acute HIV infection (SEARCH 026)
  Reported by Jules Levin
IAS Durban - HIV Cure Symposium July 16-17
E Kroon1, J Ananworanich1,2,3, LT Le4, J Intasan1, K Benjapornpong1, S Pinyakorn2,3, P Karnsomlap1, S Tipsuk1, S Rattanamanee1, J Hellmuth5, P Eamyoung1, K Eubanks6, H Yang6, N Phanuphak1 , M de Souza1,6, V Valcour5, S Spudich4; SEARCH 019 and 026 study groups.
1SEARCH, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 2U.S. Military HIV Research Program, Walter Reed Army Institute of Research, MD, USA; 3Henry M. Jackson Foundation for the Advancement of Military Medicine, MD, USA; 4Yale University, New Haven, CT, USA, 5University of California, San Francisco, 6Cooper Human Systems, MA, USA.